Advertising Driven Press Release Distribution
Advertising Driven Press Release Distribution
VANCOUVER, BC, February 10, 2022 – ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, is pleased to announce that Dr. Carlos Lifschitz has joined Else Nutrition’s Scientific Advisory Board.
Dr. Lifschitz is the Associate Physician at the Italian Hospital, Buenos Aires, Argentina and former Associate Professor at Baylor College of Medicine, Houston, Texas, USA. He is a member of the European and Latin American Societies for Pediatric gastroenterology, Hepatology and Nutrition and of the International Editorial Board of the journal Pediatric Gastroenterology, Hepatology and Nutrition (PGHN). Dr. Lifschitz is an acclaimed author of 95 peer reviewed publications and 2 books.
“We are very pleased that Dr. Lifschitz has joined our Advisory Board. He is an esteemed expert in the field of Pediatric Gastroenterology and Nutrition and his vast experience will help serve us in a profound way along our pathway to provide real, Clean Label, Plant-Based nutrition options to wanting families worldwide,” said Hamutal Yitzhak, CEO of Else Nutrition.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The Company recently received the World Plant-Based Award for “Best dairy alternative product” in New York at World Plant-Based Expo in late 2021. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
Investor Relations Contact:
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Hi3G selects Polystar and Cubro to deliver advanced Customer and Service Assurance solution for new 5G network and services
Klaiyi Hair Announces The Dates For Their Black Friday And Cyber Monday Sale 2021
Agnieszka Blum, MD, PhD has been promoted to the Management Board of Ardigen to strengthen drug discovery expertise.
Florida’s the best state for veterans. The Florida Virtual Expo showcases the endless opportunities, resources, and benefits for military families in interactive virtual booths.
Water Tower Research Launches Coverage of IT Hardware & Communications Equipment Sectors: Initiates Coverage on Cisco Systems, Extreme Networks and Infinera.